Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

sagi habasov

1156 POSTS

Exclusive articles:

SKN | SPAC OneIM Acquisition Files for a $250 Million IPO, Formed by OneIM Executives

SPAC OneIM Acquisition has filed for a $250 million IPO, signaling a renewed push by its founders — seasoned executives from OneIM — to...

SKN | Legato Merger IV Files for $200 Million IPO as Veteran SPAC Sponsors Target Industrials and AI

Legato Merger IV, a blank check company led by seasoned SPAC executives Eric Rosenfeld and David Sgro, has filed for a $200 million initial...

SKN | Osprey Bitcoin Trust Common Units of Beneficial Interest (OBTC) Makes Public Market Debut

Osprey Bitcoin Trust’s common units of beneficial interest, trading under the ticker OBTC, have begun trading on the public market, marking a notable moment...

SKN | SanDisk Surges as Earnings Momentum and NAND Recovery Reignite Investor Optimism

SanDisk Corporation (Nasdaq: SNDK) shares jumped sharply, rising more than 9% in early trading, as investors responded to improving earnings trends and signs of...

SKN | Singaporean consulting firm HAMA Intelligence refiles for a $7 million US IPO

Singapore‑based corporate consulting firm HAMA Intelligence has refiled its registration with the U.S. Securities and Exchange Commission for a $7 million initial public offering,...

Breaking

SKN | American Century Investments Launches Emerging Markets Insights ETF on Nasdaq

Key Points: American Century Investments has launched the Emerging...

SKN | ETF Launches and Hilton’s Nasdaq Transfer Shape November 5 Listings

Key Takeaways: The November 5 IPO calendar listed five...

SKN | American Ventures Acquisition I Cuts Proposed IPO Size by 25% to $75 Million

American Ventures Acquisition I, a blank check company targeting...

SKN | Rezera Sets Terms for $200 Million IPO as GSK Signals Up to $25 Million Investment

Rezera, a clinical-stage biotechnology company developing oral NLRP3 inhibitors...
spot_imgspot_img